| Trial ID: | L5058 |
| Source ID: | NCT05939921
|
| Associated Drug: |
Metformin
|
| Title: |
Effects of Metformin Therapy on Pancreatic and Hepatic Fat Content in Patients of Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type2diabetes
|
| Interventions: |
DRUG: Metformin
|
| Outcome Measures: |
Primary: To assess the effect of metformin on Pancreatic fat and hepatic fat in T2DM patients., T2DM patients will undergo MRI, Ultrasound and Fibroscan testing to determine the level of fat in pancreas and liver., 120 days |
|
| Sponsor/Collaborators: |
Sponsor: Diabetes Foundation, India | Collaborators: National Diabetes Obesity and Cholesterol Foundation
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
|
| Enrollment: |
15
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2022-05-01
|
| Completion Date: |
2023-06-30
|
| Results First Posted: |
|
| Last Update Posted: |
2023-07-25
|
| Locations: |
Anoop misra, New Delhi, Delhi, 110048, India
|
| URL: |
https://clinicaltrials.gov/show/NCT05939921
|
